Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,19 USD | -3,71% | -1,70% | -0,95% |
Vakgebied
Aantal werknemers: 88
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Integrated Drug and Drug Delivery Solutions
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +14,31% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +14,31% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Maria Palasis
CEO | Chief Executive Officer | 59 | 01-01-15 |
Jason Cavalier
DFI | Director of Finance/CFO | 51 | 13-09-21 |
Richard Nieman
CTO | Chief Tech/Sci/R&D Officer | 61 | 11-07-22 |
Vineeta Belanger
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-19 |
John Bishop
CTO | Chief Tech/Sci/R&D Officer | 62 | 27-02-23 |
Ellen Cavaleri
IRC | Investor Relations Contact | - | 01-01-22 |
Ronan O’Brien
LAW | General Counsel | 52 | 16-10-23 |
Corinne Noyes
PRN | Corporate Officer/Principal | 56 | 01-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harlan Waksal
CHM | Chairman | 71 | 16-02-22 |
W. Smith
BRD | Director/Board Member | 68 | 19-11-19 |
James Tobin
BRD | Director/Board Member | 79 | 07-03-22 |
Edward Anderson
BRD | Director/Board Member | 74 | 01-02-19 |
C. Merrifield
BRD | Director/Board Member | 73 | 04-09-19 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 28-10-20 |
Michael Altman
BRD | Director/Board Member | 42 | 01-06-18 |
Maria Palasis
CEO | Chief Executive Officer | 59 | 01-01-15 |
Director/Board Member | 40 | 29-01-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 59 743 123 | 46 281 091 ( 77,47 %) | 0 | 77,47 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,95% | 322 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |
- Beurs
- Aandelen
- Koers LYRA
- Onderneming Lyra Therapeutics, Inc.